[1]
Decker, S.R. da R. et al. 2022. Extended infusion of cephalosporins, penicillins and carbapenems: a cost-effective point-of-view and critical appraisal of Surviving Sepsis Campaign guidelines. Journal of Evidence-Based Healthcare. 4, (Nov. 2022), e4605. DOI:https://doi.org/10.17267/2675-021Xevidence.2022.e4605.